However, in February 2022, Neuralink confirmed that monkeys had died during its tests, although denied any animal abuse. The ...

A new scam using Elon Musk's name is making the rounds, promoting "energy-saving" devices and falsely linking the Tesla and SpaceX leader to the products.

Elon Musk’s Neuralink suggests that a human patient might have successfully used the company’s brain chip to remotely control a robot. A short video clip posted Thursday shows a robot arm ...

Elon Musk’s Neuralink has tapped the University of Miami Miller School of Medicine to be the second U.S. site to test the safety and effectiveness of its brain chip. Costfoto CFOTO/Sipa USA Elon ...

The charges were dismissed. In 2022, the Ninth Circuit Court of Appeals revived the copyright case, finding there were some merits to the dispute. Servant ended its four-season run in 2023. Apple ...

A recent high school graduate and former Neuralink intern has joined meetings to review lines of code and other work history of career public servants, sparking chaos at a major government agency.

Copyright Agency’s Cultural Fund has announced $754,769 in funding for 42 Australian literary and creative organisations. The Cultural Fund provides commissions and ...

Sounds like the plot of a chaotic action movie, doesn’t it? But for far too many, this scenario is an unwelcome reality. When accidents happen, something remarkable always emerges from the chaos - ...

A diverse group of 15 different European rightsholder organisations has warned that the General-purpose AI Code of Practice (CoP) under the EU’s AI rulebook contradicts copyright law ...

Elon Musk co-founded Neuralink in 2016 to develop brain-machine ... are an example of a brain-computer interface. EEGs non-invasively record electrical activity in patients with seizures through ...

Neuralink has selected the Miami Project to Cure Paralysis and the Department of Neurological Surgery at the University of Miami Miller School of Medicine as its second Prime study location.

Miller School of Medicine is the second U.S. site to join Neuralink's PRIME study, according to a Jan. 27 news release. The investigational medical device clinical trial is assessing the safety and ...